Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
Xu-Monette, Z. Y., Wu, L., Visco, C., Tai, Y. C., Tzankov, A., Liu, W.-m., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Zhao, X. F., Choi, W. WТом:
120
Мова:
english
Журнал:
Blood
DOI:
10.1182/blood-2012-05-433334
Date:
November, 2012
Файл:
PDF, 614 KB
english, 2012